Post-approval trials of new medicines: widening use or deepening knowle?

J.C.F. van Luijn; M. Danz; J.W. Bijlsma; F.W. Gribnau; H.G.M. Leufkens

Post-approval trials of new medicines: widening use or deepening knowle?

J.C.F. van Luijn, M. Danz, J.W. Bijlsma, F.W. Gribnau, H.G.M. Leufkens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	183-191
Number of pages	9
Journal	Scandinavian Journal of Rheumatology
Volume	40
Issue number	3
Publication status	Published - 2011

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{6077dcd5312c4008a8ecdfaa4c73a510,

title = "Post-approval trials of new medicines: widening use or deepening knowle?",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "{van Luijn}, J.C.F. and M. Danz and J.W. Bijlsma and F.W. Gribnau and H.G.M. Leufkens",

year = "2011",

language = "Undefined/Unknown",

volume = "40",

pages = "183--191",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",